Boston Scientific Corporation (NYSE:BSX) Quarterly Sales Review


Quarterly Sales and EPS Roundup:

Boston Scientific Corporation (BSX) reported sales (ttm) of 8.58 Billion, whereas, 21 number of analysts estimated the mean sale of 2192.78 million. The analysts estimated sales for the higher end at 2220 million and lower end at 2173 million while the year ago reported sale was 2144.8 million.

21 number of analysts have estimated the sales of the company for the quarter, analysts estimated mean sale target of 2306.38 million while high and low sale targets are estimated at 2351 million and 2269 million respectively.

Boston Scientific Corporation (BSX) reported earning per shares for the quarter ending Jul 27 BMO, whereas, 24 number of analysts estimated the mean EPS at 0.31. The analysts estimated EPS for the higher end at 0.32 and lower end at 0.3 while the year ago reported earnings per share was 0.31.

The company has mean EPS estimate of 0.34 reported by 24 number of analyst for the quarter ending Current Qtr.(Jun2017). The analysts estimated mean EPS at 0.34 while the high and low EPS estimate stand at 0.35 and 0.33 respectively. In contrast to the year ago quarter EPS was at 0.32. EPS long term mean growth rate estimated by 6 analysts is at 10.77%, whereas, the high and low Long term growth rate estimated at 12.9 and 8.6.

Valuation Ratios of Boston Scientific Corporation (BSX) versus the Industry and Sector:

Let’s have a look at some of the important valuation ratios of the Boston Scientific Corporation (BSX). These ratios are important while doing valuation of the company or the shares of the company.

Boston Scientific Corporation (BSX) currently has P/E (Price to Earnings) ratio of 88.68 while the company’s industry has 41.87 P/E and the sector P/E is 17.23. Similarly, the company’s last 5 years high P/E ratio is 85.85 and low P/E is 85.85, whereas, the industry’s and sector’s  high P/E for the past year is 76.11 and 43.61 respectively and low P/E ratio for the last 5 years is 21.06 for the industry and 23.34 for the Sector.

Beta is also an important valuation ratio for analyzing the stock of the company, BSX has Beta of 1.12 while its industry and Sector’s beta remains at 0.9 and 0.89 respectively.

Price to Sale ratio of BSX stands at 4.43 while Price to Book Ratio stands at 5.39. Its Price to Cash Flow ratio shows the value of 30.31, whereas, the industry and sector ratio of Price to Cash Flow ticked at 20.74 and 10.42 respectively.

5 Year Growth Rate Analysis:

Growth rates are very important while analyzing the long term growth and valuation of a certain company.

5 year sales growth rate is an important factor for valuation analysis, the 5 year sales growth of Boston Scientific Corporation (BSX) stands at 1.93 while the industry’s and the sector’s growth for next 5 years ticked at 2.98 and 10.49 respectively. The company’s 5 year Earnings per share growth and Capital Spending growth remains at -2.79 and 10.03.

Boston Scientific Corporation (BSX) Trading Statistics:

The company surged 0.69% and closed its last trading session at $27.59. The market capitalization of the company is at $37.93 Billion. The stock touched 52-week High of $28.51 on 06/19/17 and 52-week Low of $19.67 on 12/01/16. The stock currently has Weekly Volatility of 1.03% and Monthly Volatility of 1.39%. The Beta for the company stands at 1.12 and its Average True Range (ATR) shows a value of 0.38.